ADDENDUM N° 2 TO EXCLUSIVE SUPPLY AGREEMENT for recombinant L-AsparaginaseErytech Pharma S.A. • July 10th, 2017 • Biological products, (no disgnostic substances)
ERYTECH Pharma S.A, a company incorporated under the laws of the Republic of France (n° 479 560 013 RCS Lyon; VAT No. FR 10479560013)), having its registered head office at Bâtiment Adenine, 60 avenue Rockefeller, 69008 Lyon, France, represented by Mr Gil Beyen, Chief Executive Officer, and by Mr Jérôme Bailly, Qualified Person,
ADDENDUM N° 2 TO EXCLUSIVE SUPPLY AGREEMENTExclusive Supply Agreement • July 10th, 2017 • Erytech Pharma S.A. • Biological products, (no disgnostic substances)
ERYTECH Pharma S.A, a company incorporated under the laws of the Republic of France (n° 479 560 013 RCS Lyon; VAT No. FR 10479560013)), having its registered head office at Bâtiment Adenine, 60 avenue Rockefeller, 69008 Lyon, France, represented by Mr GIl Beyen, Chief Executive Officer, and by Mr Jérôme Bailly, Qualified Person,
ADDENDUM N°3 TO THE AGREEMENTErytech Pharma S.A. • July 10th, 2017 • Biological products, (no disgnostic substances)
• ERYTECH Pharma, S.A. with a share capital of 792 461,10 euros €, having its registered head office in Lyon 08, Bâtiment Adénine, 60 avenue Rockefeller, registered with the Trade and Companies Registry of Lyon under the number 479 560 013, represented by Mr Gil BEYEN, Chief Executive Officer, (“ERYTECH”)
